KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quest Diagnostics (DGX) Change in Cash (2016 - 2025)

Quest Diagnostics' Change in Cash history spans 17 years, with the latest figure at -$12.0 million for Q4 2025.

  • For Q4 2025, Change in Cash rose 94.42% year-over-year to -$12.0 million; the TTM value through Dec 2025 reached -$129.0 million, up 5.84%, while the annual FY2025 figure was -$129.0 million, 5.84% up from the prior year.
  • Change in Cash for Q4 2025 was -$12.0 million at Quest Diagnostics, down from $113.0 million in the prior quarter.
  • Across five years, Change in Cash topped out at $543.0 million in Q4 2023 and bottomed at -$670.0 million in Q2 2021.
  • The 5-year median for Change in Cash is -$69.5 million (2022), against an average of -$36.9 million.
  • The largest annual shift saw Change in Cash crashed 322.22% in 2022 before it surged 2800.0% in 2024.
  • A 5-year view of Change in Cash shows it stood at -$115.0 million in 2021, then plummeted by 234.78% to -$385.0 million in 2022, then soared by 241.04% to $543.0 million in 2023, then plummeted by 139.59% to -$215.0 million in 2024, then surged by 94.42% to -$12.0 million in 2025.
  • Per Business Quant, the three most recent readings for DGX's Change in Cash are -$12.0 million (Q4 2025), $113.0 million (Q3 2025), and $131.0 million (Q2 2025).